Tag: RootsAnalysis
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion - Roots Analysis'
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community
The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%- "Roots Analysis"
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
The patient recruitment and retention services market - "Roots Analysis"
Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.” https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html For more information, p...
The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030\RootsAnalysis
The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030\RootsAnalysis
The “Novel Vaccine Delivery Devices Market, 2019-2030{RootsAnalysis}
The “Novel Vaccine Delivery Devices Market, 2019-2030{RootsAnalysis}
Over 130 novel vaccine delivery devices, including marketed / under development products(RootsAnalysis)
Over 130 novel vaccine delivery devices, including marketed / under development products(RootsAnalysis)
The novel vaccine delivery devices market is projected to grow at an annualized rate of ~20%:By RootsAnalysis:
The novel vaccine delivery devices market is projected to grow at an annualized rate of ~20%:By RootsAnalysis:
The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030<>
The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030<<RootsAnalysis>>
More than 100 industry players and over 60 non-industry players currently claim to manufacture\RootsAnalysis
More than 100 industry players and over 60 non-industry players currently claim to manufacture\RootsAnalysis
The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%{RootsAnalysis}
The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%{RootsAnalysis}
The ‘Patient Recruitment and Retention Services, 2019-2030(RootsAnalysis)
The ‘Patient Recruitment and Retention Services, 2019-2030(RootsAnalysis)
Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services:BY ROOTSANALYSIS:
Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services:BY ROOTSANALYSIS:
The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030:By RootsAnalysis:
The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030:By RootsAnalysis:
The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030(RootsAnalysis)
The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030(RootsAnalysis)
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market:By RootsAnalysis
Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market:By RootsAnalysis
